SCHEMBL5820332

SCHEMBL5820332

COc1ccc(C2CCCCN2CCC(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 9/20 0.54
ALDH1A1 P00352 5/20 0.54
HTT P42858 4/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
MAPK1 P28482 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
USP2 O75604 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
MAPT P10636 9/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
GAA P10253 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
HCRTR1 O43613 1/20 0.46
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5796637 0.92 LMNA (0.59) LMNAALDH1A1HTTSMN1; SMN2MAPK1
SCHEMBL5794585 0.86 SMN1; SMN2 (0.44) LMNAALDH1A1HTTSMN1; SMN2MAPK1
SCHEMBL5806244 0.84 SMN1; SMN2 (0.43) LMNAALDH1A1HTTSMN1; SMN2MAPK1
SCHEMBL5795178 0.81 SMN1; SMN2 (0.54) LMNAALDH1A1HTTSMN1; SMN2NPSR1
SCHEMBL5794482 0.80 MAPT (0.56) LMNAALDH1A1HTTSMN1; SMN2MAPK1
SCHEMBL5794095 0.79 SMN1; SMN2 (0.42) LMNAALDH1A1HTTSMN1; SMN2MAPK1
SCHEMBL5796898 0.78 UTS2R (0.42) ALDH1A1HTTSMN1; SMN2MAPK1MAPT
SCHEMBL5793771 0.76 SMN1; SMN2 (0.41) ALDH1A1HTTSMN1; SMN2MAPK1MAPT
SCHEMBL5793348 0.76 MAPT (0.48) ALDH1A1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL5793764 0.76 MAPT (0.46) ALDH1A1SMN1; SMN2MAPK1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006015279-A1 HETEROCYCLIC DIAMINE COMPOUNDS AS LIGANDS OF THE MELANIN CONCENTRATING HORMONE RECEPTOR USEFUL FOR THE TREATMENT OF OBESITY, DIABETES, EATING AND SEXUAL DISORDERS NEUROGEN CORPORATION (US) 2006-02-09 WO claimed